222 related articles for article (PubMed ID: 32910430)
21. Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review.
Lan TY; Chen YS; Cheng CF; Huang ST; Shen CY; Hsu PN
Lupus; 2021 Oct; 30(11):1849-1855. PubMed ID: 34325541
[TBL] [Abstract][Full Text] [Related]
22. Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab.
Walter O; Treiner E; Bonneville F; Mengelle C; Vergez F; Lerebours F; Delobel P; Liblau R; Martin-Blondel G;
N Engl J Med; 2019 Apr; 380(17):1674-1676. PubMed ID: 30969500
[No Abstract] [Full Text] [Related]
23. Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study.
Jilek S; Jaquiéry E; Hirsch HH; Lysandropoulos A; Canales M; Guignard L; Schluep M; Pantaleo G; Du Pasquier RA
Lancet Neurol; 2010 Mar; 9(3):264-72. PubMed ID: 20117055
[TBL] [Abstract][Full Text] [Related]
24. Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Volk T; Warnatz K; Marks R; Urbach H; Schluh G; Strohmeier V; Rojas-Restrepo J; Grimbacher B; Rauer S
J Neurol; 2022 Feb; 269(2):973-981. PubMed ID: 34196768
[TBL] [Abstract][Full Text] [Related]
25. A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy.
Sanjo N; Nose Y; Shishido-Hara Y; Mizutani S; Sekijima Y; Aizawa H; Tanizawa T; Yokota T
J Neurol; 2019 Feb; 266(2):369-377. PubMed ID: 30511098
[TBL] [Abstract][Full Text] [Related]
26. Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression.
Grewal J; Dalal P; Bowman M; Kaya B; Otero JJ; Imitola J
J Neurovirol; 2016 Oct; 22(5):683-687. PubMed ID: 27273076
[TBL] [Abstract][Full Text] [Related]
27. [Two patients with progressive multifocal leukoencephalopathy with immune response against JC virus showing good long-term outcome by combination therapy of mefloquine, mirtazapine, and risperidone].
Akagawa Y; Ueno A; Ikeda J; Ishii W; Shishido-Hara Y; Sekijima Y
Rinsho Shinkeigaku; 2018 May; 58(5):324-331. PubMed ID: 29710027
[TBL] [Abstract][Full Text] [Related]
28. Progressive multifocal leukoencephalopathy in a patient with lymphoma and presumptive hyper IgE syndrome.
Gocmen R; Acar NP; Cagdas D; Kurne A
J Neurovirol; 2017 Aug; 23(4):632-636. PubMed ID: 28643229
[TBL] [Abstract][Full Text] [Related]
29. Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.
Bellizzi A; Nardis C; Anzivino E; Rodìo D; Fioriti D; Mischitelli M; Chiarini F; Pietropaolo V
J Neurovirol; 2012 Feb; 18(1):1-11. PubMed ID: 22290500
[TBL] [Abstract][Full Text] [Related]
30. Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome.
Gheuens S; Bord E; Kesari S; Simpson DM; Gandhi RT; Clifford DB; Berger JR; Ngo L; Koralnik IJ
J Virol; 2011 Jul; 85(14):7256-63. PubMed ID: 21543472
[TBL] [Abstract][Full Text] [Related]
31. Brain Lesion in the Setting of Chronic Rituximab Treatment.
Yazdani M; Antonucci M; Spampinato MV
JAMA Oncol; 2020 Jul; 6(7):1093-1094. PubMed ID: 32463440
[No Abstract] [Full Text] [Related]
32. [Progressive multifocal encephalopathy in neurological practice].
Putilina MV; Ermoshkina NY; Sigitov IS; Sidelnikova LV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):95-105. PubMed ID: 29376991
[TBL] [Abstract][Full Text] [Related]
33. Progressive multifocal leukoencephalopathy despite immune recovery in a HIV/HCV co-infected patient.
Hentzien M; Guihot A; de Maindreville D; Tabary T; Brodard V; Vieillard V; Adle-Biassette H; Bani-Sadr F
J Neurovirol; 2020 Aug; 26(4):607-610. PubMed ID: 32458280
[TBL] [Abstract][Full Text] [Related]
34. Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals.
Crossley KM; Agnihotri S; Chaganti J; Rodriguez ML; McNally LP; Venna N; Turbett SE; Gutman M; Morey A; Koralnik IJ; Brew BJ
J Neurovirol; 2016 Aug; 22(4):541-5. PubMed ID: 26727910
[TBL] [Abstract][Full Text] [Related]
35. Progressive multifocal leukoencephalopathy.
Weissert R
J Neuroimmunol; 2011 Feb; 231(1-2):73-7. PubMed ID: 20937530
[TBL] [Abstract][Full Text] [Related]
36. [Progressive multifocal leukoencephalopathy in a patient with multiple myeloma].
Willert CB; Engsig FN; Eskildsen HW; Andersen AB
Ugeskr Laeger; 2014 Dec; 176(49):. PubMed ID: 25497861
[TBL] [Abstract][Full Text] [Related]
37. An autopsy case of progressive multifocal leukoencephalopathy after rituximab therapy for malignant lymphoma.
Muto R; Sugita Y; Momosaki S; Ito Y; Wakugawa Y; Ohshima K
Neuropathology; 2019 Feb; 39(1):58-63. PubMed ID: 30511425
[TBL] [Abstract][Full Text] [Related]
38. Progressive multifocal leukoencephalopathy in Zambia is caused by JC virus with prototype regulatory region.
Mubanga E; Patel A; Siddiqi OK; Hanson BA; Dang X; Lakhi S; Mulundu G; Bender N; Koralnik IJ
J Neurovirol; 2019 Aug; 25(4):475-479. PubMed ID: 31028690
[TBL] [Abstract][Full Text] [Related]
39. Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. A Case Report and Literature Review.
Felli V; Di Sibio A; Anselmi M; Gennarelli A; Sucapane P; Splendiani A; Catalucci A; Marini C; Gallucci M
Neuroradiol J; 2014 Dec; 27(6):657-64. PubMed ID: 25489887
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis of progressive multifocal leukoencephalopathy--revisited.
White MK; Khalili K
J Infect Dis; 2011 Mar; 203(5):578-86. PubMed ID: 21227915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
